{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:31:50Z","timestamp":1787841110432,"version":"build-2784847793"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>\n                    Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, affecting about one-quarter of the general population worldwide. Owing to the prevalence and high burden of NAFLD in special groups, this study aimed to examine the features of screening strategies for NAFLD in special populations. We carried out a scoping review using the main online databases (Medline (PubMed), Scopus, and Web of Science) with the following keywords: Screening, Nonalcoholic fatty liver, willingness to pay, economic evaluation, and preferences. We included publications from January 1, 2000, to August 27, 2024, which focused on NAFLD screening strategies in special populations. Quality assessment of the included studies was performed using the QADAS checklist. The AUC ranged from 0.5 to 93.30, the maximum value corresponding to the WC test in the MAFLD population. The highest sensitivity and specificity were related to the BMI test (96.89) and the BRI test in the T\n                    <jats:sub>2<\/jats:sub>\n                    DM MAFLD population. The cutoff value ranged from -1.44 to 876.17, the highest value about the TYG-WC test in obese individuals without T\n                    <jats:sub>2<\/jats:sub>\n                    DM. Additionally, the highest PLR and PPV were related to NAFLD-MS in the high-risk MetS population. The highest AUROC was observed for the SHSI test in the obese population. FLI, TYG-WC, TYG-BM, and BMI were among the best NAFLD screening tests in different populations. NAFLD-LFS, NHTR, and LAPI tests were found to be the best and most applicable tests in special populations.\n                  <\/jats:p>","DOI":"10.4103\/jehp.jehp_169_25","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:01:33Z","timestamp":1774983693000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Surveying the features of screening strategies for non-alcoholic fatty liver disease: A scoping review"],"prefix":"10.4103","volume":"15","author":[{"given":"Nazanin","family":"Mir","sequence":"first","affiliation":[{"name":"Health Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran"},{"name":"School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid R","family":"Baradaran","sequence":"additional","affiliation":[{"name":"Epidemiology, Endocrine Research Center, Institute of Endocrinology and Metabolism, University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seidamir Pasha","family":"Tabaeian","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin Abolhasanbeigi","family":"Gallehzan","sequence":"additional","affiliation":[{"name":"Health Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziz","family":"Rezapour","sequence":"additional","affiliation":[{"name":"Health Economics, Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3]]},"reference":[{"key":"R1-20260331","doi-asserted-by":"crossref","first-page":"686","DOI":"10.47102\/annals-acadmedsg.2022284","article-title":"Non-alcoholic fatty liver disease screening in type 2 diabetes mellitus: A cost-effectiveness and price threshold analysis","volume":"51","author":"Choo","year":"2022","journal-title":"Ann Acad Med Singap"},{"key":"R2-20260331","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/MCG.0000000000001739","article-title":"Global burden of nonalcoholic fatty liver disease, 1990 to 2019: Findings from the global burden of disease study 2019","volume":"57","author":"Jiang","year":"2023","journal-title":"J Clin Gastroenterol"},{"key":"R4-20260331","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jhep.2010.04.008","article-title":"A position statement on NAFLD\/NASH based on the EASL 2009 special conference","volume":"53","author":"Ratziu","year":"2010","journal-title":"J Hepatol"},{"key":"R5-20260331","doi-asserted-by":"crossref","first-page":"i4428","DOI":"10.1136\/bmj.i4428","article-title":"Non-alcoholic fatty liver disease (NAFLD): Summary of NICE guidance","volume":"354","author":"Glen","year":"2016","journal-title":"BMJ"},{"key":"R6-20260331","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1665-2681(19)31822-8","article-title":"Metabolic syndrome and non-alcoholic fatty liver disease","volume":"8","author":"Almeda-Vald\u00e9s","year":"2009","journal-title":"Ann Hepatol"},{"key":"R7-20260331","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/MCG.0000000000001270","article-title":"The prevalence of lean\/nonobese nonalcoholic fatty liver disease: A systematic review and meta-analysis","volume":"54","author":"Shi","year":"2020","journal-title":"J Clin Gastroenterol"},{"key":"R8-20260331","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/apt.15673","article-title":"Modelling NAFLD disease burden in four Asian regions\u20142019\u20102030","volume":"51","author":"Estes","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"R9-20260331","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1053\/j.gastro.2017.01.003","article-title":"Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation","volume":"152","author":"Goldberg","year":"2017","journal-title":"Gastroenterology"},{"key":"R10-20260331","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.26717","article-title":"Extrahepatic complications of nonalcoholic fatty liver disease","volume":"59","author":"Armstrong","year":"2014","journal-title":"Hepatology"},{"key":"R11-20260331","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-021-12326-y","article-title":"Non-communicable diseases in the southwest of Iran: Profile and baseline data from the Shahrekord PERSIAN Cohort Study","volume":"21","author":"Ahmadi","year":"2021","journal-title":"BMC Public Health"},{"key":"R12-20260331","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"R13-20260331","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non\u2010alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"R14-20260331","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"R15-20260331","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000443344","article-title":"EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"9","year":"2016","journal-title":"Obes Facts"},{"key":"R16-20260331","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"R17-20260331","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","article-title":"Updated methodological guidance for the conduct of scoping reviews","volume":"18","author":"Peters","year":"2020","journal-title":"JBI Evid Synth"},{"key":"R18-20260331","doi-asserted-by":"crossref","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"key":"R19-20260331","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-6-9","article-title":"Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies","volume":"6","author":"Whiting","year":"2006","journal-title":"BMC Med Res Methodol"},{"key":"R20-20260331","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ijo.2017.116","article-title":"High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance","volume":"41","author":"Cai","year":"2017","journal-title":"Int J Obes"},{"key":"R21-20260331","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/DMSO.S189544","article-title":"The fatty liver index, a simple and useful predictor of metabolic syndrome: Analysis of the Korea National Health and Nutrition Examination Survey 2010\u20132011","volume":"12","author":"Khang","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R22-20260331","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/diseases11010010","article-title":"Exploring the validity of available markers and indices in the diagnosis of nonalcoholic fatty liver disease (NAFLD) in people with type 2 diabetes in Saudi Arabia","volume":"11","author":"Ajabnoor","year":"2023","journal-title":"Diseases"},{"key":"R23-20260331","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1507\/endocrj.EJ21-0563","article-title":"Prediction and validation of nonalcoholic fatty liver disease by fatty liver index in a Japanese population","volume":"69","author":"Takahashi","year":"2022","journal-title":"Endocr J"},{"key":"R24-20260331","doi-asserted-by":"crossref","first-page":"1035418","DOI":"10.3389\/fendo.2022.1035418","article-title":"Optimum non-invasive predictive indicators for metabolic dysfunction-associated fatty liver disease and its subgroups in the Chinese population: A retrospective case-control study","volume":"13","author":"Liu","year":"2022","journal-title":"Front Endocrinol"},{"key":"R25-20260331","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1507\/endocrj.EJ23-0227","article-title":"A prediction model of liver fat fraction and presence of non-alcoholic fatty liver disease (NAFLD) among patients with overweight or obesity","volume":"70","author":"Chen","year":"2023","journal-title":"Endocr J"},{"key":"R26-20260331","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s12890-021-01759-1","article-title":"Novel screening model of obstructive sleep apnea for snorers with suspected NAFLD undergoing liver sonography","volume":"21","author":"Lu","year":"2021","journal-title":"BMC Pulm Med"},{"key":"R27-20260331","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/MEG.0b013e3283564ee5","article-title":"The alanine aminotransferase to triglycerides ratio as a marker to identify nonalcoholic fatty liver disease","volume":"24","author":"Simental-Mend\u00eda","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R28-20260331","doi-asserted-by":"crossref","first-page":"2513175","DOI":"10.1155\/2023\/2513175","article-title":"Relationship between uric acid to high density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease in nonoverweight\/obese patients with type 2 diabetes","volume":"2023","author":"Cui","year":"2023","journal-title":"Int J Endocrinol"},{"key":"R29-20260331","doi-asserted-by":"crossref","first-page":"e23619","DOI":"10.1097\/MD.0000000000023619","article-title":"Comparison of noninvasive scoring systems for the prediction of nonalcoholic fatty liver disease in metabolic syndrome patients","volume":"99","author":"Saokaew","year":"2020","journal-title":"Medicine"},{"key":"R30-20260331","first-page":"103","article-title":"Evaluation of different scores to predict non-alcoholic fatty liver disease in patients with type 2 diabetes","volume":"8","author":"Angelidi","year":"2017","journal-title":"Hell J Atheroscler"},{"key":"R31-20260331","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4103\/ijem.IJEM_31_18","article-title":"Neck circumference to height ratio is a reliable predictor of liver stiffness and nonalcoholic fatty liver disease in prediabetes","volume":"22","author":"Mondal","year":"2018","journal-title":"Indian J Endocrinol Metabol"},{"key":"R32-20260331","doi-asserted-by":"crossref","first-page":"648","DOI":"10.4314\/ahs.v22i1.75","article-title":"Predictivity of fatty liver index for non-alcoholic fatty liver disease in lean females with polycystic ovary syndrome","volume":"22","author":"Ar\u0131kan","year":"2022","journal-title":"Afr Health Sci"},{"key":"R33-20260331","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4103\/jrms.JRMS_292_20","article-title":"Evaluation of the predictive value of body mass index (BMI), waist circumference, and visceral fat to differentiate non-alcoholic fatty liver (NAFLD) in women with polycystic ovary syndrome","volume":"27","author":"Eslami","year":"2022","journal-title":"J Res Med Sci"},{"key":"R34-20260331","doi-asserted-by":"crossref","first-page":"e0224942","DOI":"10.1371\/journal.pone.0224942","article-title":"The ZJU index is a powerful surrogate marker for NAFLD in severely obese North American women","volume":"14","author":"Fu","year":"2019","journal-title":"PLoS One"},{"key":"R35-20260331","doi-asserted-by":"crossref","first-page":"e00042","DOI":"10.14309\/ctg.0000000000000042","article-title":"Role of fatty liver index and metabolic factors in the prediction of nonalcoholic fatty liver disease in a lean population receiving health checkup","volume":"10","author":"Hsu","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"R36-20260331","doi-asserted-by":"crossref","first-page":"e8192","DOI":"10.1097\/MD.0000000000008192","article-title":"Waist-to-height ratio is better than body mass index and waist circumference as a screening criterion for metabolic syndrome in Han Chinese adults","volume":"96","author":"Yang","year":"2017","journal-title":"Medicine"},{"key":"R37-20260331","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3390\/diagnostics10100809","article-title":"Clinical and biochemical predictors of nonalcoholic fatty liver disease among type 2 diabetes mellitus patients at primary health Care level in south western Saudi Arabia","volume":"10","author":"Al Humayed","year":"2020","journal-title":"Diagnostics"},{"key":"R38-20260331","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.orcp.2021.09.002","article-title":"Accuracy of ultrasound diagnosis of nonalcoholic fatty liver disease in patients with classes II and III obesity: A pathological image study","volume":"15","author":"Leivas","year":"2021","journal-title":"Obes Res Clin Pract"},{"key":"R39-20260331","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12902-022-00993-w","article-title":"Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes","volume":"22","author":"Li","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"R40-20260331","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.3390\/biomedicines10092251","article-title":"Triglyceride glucose-waist circumference (TyG-WC) is a reliable marker to predict non-alcoholic fatty liver disease","volume":"10","author":"Song","year":"2022","journal-title":"Biomedicines"},{"key":"R41-20260331","first-page":"82","article-title":"Prevalence and predictors of non-alcoholic fatty liver disease as defined by the fatty liver index in a type 2 diabetes population","volume":"89","author":"Silaghi","year":"2016","journal-title":"Clujul Med"},{"key":"R42-20260331","doi-asserted-by":"crossref","first-page":"9047324","DOI":"10.1155\/2019\/9047324","article-title":"Abdominal obesity as a predictive factor of nonalcoholic fatty liver disease assessed by ultrasonography and transient elastography in polycystic ovary syndrome and healthy women","volume":"2019","author":"Tantanavipas","year":"2019","journal-title":"Biomed Res Int"},{"key":"R43-20260331","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/jgh.13814","article-title":"Fatty liver index and hepatic steatosis index for prediction of non\u2010alcoholic fatty liver disease in type 1 diabetes","volume":"33","author":"Svikl\u0101ne","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"R44-20260331","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4103\/2230-8210.163172","article-title":"Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes","volume":"19","author":"Sanyal","year":"2015","journal-title":"Indian J Endocrinol Metab"},{"key":"R45-20260331","doi-asserted-by":"crossref","first-page":"1083032","DOI":"10.3389\/fendo.2023.1083032","article-title":"Prediction of MAFLD and NAFLD using different screening indexes: A cross-sectional study in US adults","volume":"14","author":"Peng","year":"2023","journal-title":"Front Endocrinol"},{"key":"R46-20260331","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1097\/CM9.0000000000000503","article-title":"Validation of fatty liver index and hepatic steatosis index for screening of non-alcoholic fatty liver disease in adults with obstructive sleep apnea hypopnea syndrome","volume":"132","author":"Chen","year":"2019","journal-title":"Chin Med J"},{"key":"R47-20260331","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1186\/s12889-023-15365-9","article-title":"Comparison of the prognostic value of a comprehensive set of predictors in identifying risk of metabolic-associated fatty liver disease among employed adults","volume":"23","author":"Yang","year":"2023","journal-title":"BMC Public Health"},{"key":"R48-20260331","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.3748\/wjg.v26.i15.1792","article-title":"Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease","volume":"26","author":"Zeng","year":"2020","journal-title":"World J Gastroenterol"},{"key":"R49-20260331","doi-asserted-by":"crossref","first-page":"951689","DOI":"10.3389\/fendo.2022.951689","article-title":"Potential screening indicators for early diagnosis of NAFLD\/MAFLD and liver fibrosis: Triglyceride glucose index\u2013related parameters","volume":"13","author":"Xue","year":"2022","journal-title":"Front Endocrinol"},{"key":"R50-20260331","doi-asserted-by":"crossref","first-page":"1340644","DOI":"10.3389\/fendo.2024.1340644","article-title":"Association between the ZJU index and risk of new-onset non-alcoholic fatty liver disease in non-obese participants: A Chinese longitudinal prospective cohort study","volume":"15","author":"Zheng","year":"2024","journal-title":"Front Endocrinol"},{"key":"R51-20260331","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3803\/EnM.2021.1074","article-title":"Non-laboratory-based simple screening model for nonalcoholic fatty liver disease in patients with type 2 diabetes developed using multi-center cohorts","volume":"36","author":"Kim","year":"2021","journal-title":"Endocrinol Metab"},{"key":"R52-20260331","doi-asserted-by":"crossref","first-page":"e000913","DOI":"10.1136\/bmjgast-2022-000913","article-title":"Fatty Liver Index is a valid predictor of non-alcoholic fatty liver disease (NAFLD) in pregnancy","volume":"9","author":"Koralegedara","year":"2022","journal-title":"BMJ Open Gastroenterol"},{"key":"R53-20260331","doi-asserted-by":"crossref","first-page":"e7041","DOI":"10.1097\/MD.0000000000007041","article-title":"Triglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects","volume":"96","author":"Zhang","year":"2017","journal-title":"Medicine"},{"key":"R54-20260331","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/met.2020.0109","article-title":"Triglyceride glucose index and related parameters (triglyceride glucose-body mass index and triglyceride glucose-waist circumference) identify nonalcoholic fatty liver and liver fibrosis in individuals with overweight\/obesity","volume":"19","author":"Khamseh","year":"2021","journal-title":"Metab Syndr Relat Disord"},{"key":"R55-20260331","doi-asserted-by":"crossref","first-page":"20470","DOI":"10.1038\/s41598-023-47269-4","article-title":"Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population","volume":"13","author":"Zeng","year":"2023","journal-title":"Sci Rep"},{"key":"R56-20260331","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/s12890-024-03166-8","article-title":"Triglyceride-glucose index and combined indicators: Effective indicators for screening NAFLD in snoring patients","volume":"24","author":"Cai","year":"2024","journal-title":"BMC Pulm Med"},{"key":"R58-20260331","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.2169\/internalmedicine.1097-22","article-title":"Utility of indices obtained during medical checkups for predicting fatty liver disease in non-obese people","volume":"62","author":"Otsubo","year":"2023","journal-title":"Intern Med"},{"key":"R59-20260331","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12944-021-01560-3","article-title":"Comparison of obesity-related indices for identifying nonalcoholic fatty liver disease: A population-based cross-sectional study in China","volume":"20","author":"Fangfei","year":"2021","journal-title":"Lipids Health Dis (Web)"},{"key":"R60-20260331","doi-asserted-by":"crossref","first-page":"e456","DOI":"10.1002\/edm2.456","article-title":"Fatty liver biomarkers and insulin resistance indices in the prediction of non\u2010alcoholic fatty liver disease in Ghanaian patients","volume":"6","author":"Bockarie","year":"2023","journal-title":"Endocrinol Diabetes Metab"},{"key":"R61-20260331","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00592-017-1024-8","article-title":"The ZJU index is a powerful index for identifying NAFLD in the general Chinese population","volume":"54","author":"Li","year":"2017","journal-title":"Acta Diabetol"},{"key":"R62-20260331","doi-asserted-by":"crossref","first-page":"e0263826","DOI":"10.1371\/journal.pone.0263826","article-title":"Neck circumference as a screening measure for identifying NAFLD among a group of academic employees in Bangkok, Thailand","volume":"17","author":"Suwimol","year":"2022","journal-title":"PLoS One"},{"key":"R63-20260331","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s12072-020-10065-7","article-title":"Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease","volume":"14","author":"Cen","year":"2020","journal-title":"Hepatol Int"},{"key":"R64-20260331","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.3390\/diagnostics11122233","article-title":"Fatty liver index for predicting nonalcoholic fatty liver disease in an asymptomatic Korean population","volume":"11","author":"Cho","year":"2021","journal-title":"Diagnostics"},{"key":"R65-20260331","doi-asserted-by":"crossref","first-page":"362147","DOI":"10.1155\/2012\/362147","article-title":"Role of body mass index, waist\u2010to\u2010height and waist\u2010to\u2010hip ratio in prediction of nonalcoholic fatty liver disease","volume":"2012","author":"Zheng","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"R66-20260331","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.clnu.2019.02.024","article-title":"Fatty liver index (FLI) and prediction of new cases of non-alcoholic fatty liver disease: A population-based study of northern Iran","volume":"39","author":"Motamed","year":"2020","journal-title":"Clin Nutr"},{"key":"R67-20260331","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12944-023-01802-6","article-title":"Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis","volume":"22","author":"Ebrahimi","year":"2023","journal-title":"Lipids Health Dis"}],"container-title":["Journal of Education and Health Promotion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jehp.jehp_169_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:42:47Z","timestamp":1787838167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jehp.jehp_169_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jehp.jehp_169_25","relation":{},"ISSN":["2277-9531","2319-6440"],"issn-type":[{"value":"2277-9531","type":"print"},{"value":"2319-6440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"2025-01-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}